Envestnet Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
10,326
+3,869
| +60% | +$252K | ﹤0.01% | 3496 |
|
|
2025
Q1 | $432K | Buy |
6,457
+1,527
| +31% | +$102K | ﹤0.01% | 3706 |
|
|
2024
Q4 | $273K | Buy |
4,930
+1,256
| +34% | +$69.4K | ﹤0.01% | 3941 |
|
|
2024
Q3 | $219K | Buy |
+3,674
| New | +$219K | ﹤0.01% | 3982 |
|
|
2020
Q1 | – | Sell |
-13,330
| Closed | -$822K | – | 2967 |
|
|
2019
Q4 | $822K | Buy |
13,330
+639
| +5% | +$39.4K | ﹤0.01% | 2151 |
|
|
2019
Q3 | $925K | Sell |
12,691
-115
| -0.9% | -$8.38K | ﹤0.01% | 1991 |
|
|
2019
Q2 | $1.05M | Sell |
12,806
-971
| -7% | -$79.8K | ﹤0.01% | 1909 |
|
|
2019
Q1 | $972K | Sell |
13,777
-863
| -6% | -$60.9K | ﹤0.01% | 1923 |
|
|
2018
Q4 | $659K | Buy |
+14,640
| New | +$659K | ﹤0.01% | 1981 |
|
|
2018
Q3 | – | Sell |
-2,997
| Closed | -$199K | – | 1305 |
|
|
2018
Q2 | $199K | Sell |
2,997
-239
| -7% | -$15.9K | ﹤0.01% | 1666 |
|
|
2018
Q1 | $188K | Sell |
3,236
-45
| -1% | -$2.61K | ﹤0.01% | 1613 |
|
|
2017
Q4 | $211K | Sell |
3,281
-382
| -10% | -$24.6K | ﹤0.01% | 1820 |
|
|
2017
Q3 | $192K | Buy |
3,663
+326
| +10% | +$17.1K | ﹤0.01% | 1855 |
|
|
2017
Q2 | $156K | Sell |
3,337
-156
| -4% | -$7.29K | ﹤0.01% | 1962 |
|
|
2017
Q1 | $172K | Buy |
3,493
+1,577
| +82% | +$77.7K | ﹤0.01% | 1982 |
|
|
2016
Q4 | $117K | Sell |
1,916
-671
| -26% | -$41K | ﹤0.01% | 2117 |
|
|
2016
Q3 | $172K | Buy |
+2,587
| New | +$172K | ﹤0.01% | 2085 |
|
|
2015
Q4 | – | Sell |
-1,627
| Closed | -$64K | – | 2975 |
|
|
2015
Q3 | $64K | Buy |
+1,627
| New | +$64K | ﹤0.01% | 2539 |
|